Rybelsus, 7 mg tablets, Oral medication for type 2 diabetes management, 30 tablets

Rybelsus is an oral medication specifically designed for the management of type 2 diabetes. Each pack contains 30 tablets, each with a dosage of 7 mg. The key active ingredient in Rybelsus is semaglutide, a glucagon-like peptide-1 (GLP-1) receptor agonist. Semaglutide works by mimicking the effects of incretin hormones in the body, which help regulate blood sugar levels. By stimulating insulin secretion and reducing glucagon production, Rybelsus helps lower blood glucose levels in patients with type 2 diabetes. This mechanism of action not only improves glycemic control but also supports weight management in individuals with diabetes. Rybelsus offers a convenient and effective way to incorporate GLP-1 receptor agonist therapy into diabetes treatment regimens, promoting better health outcomes for patients.